NCI-14465 is an ectonucleotide pyrophosphatase/phosphodiesterase ( ENPP1 ) inhibitor with an IC 50 of 26.4 μM. NCI-14465 can be used in cancer research.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phosphodiesterase (PDE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.